Question 1

What is OBILTOXAXIMAB used for?

Accepted Answer

OBILTOXAXIMAB (brand name Anthim) is a Other indicated for 5.1 ) The effectiveness of ANTHIM is based solely on efficacy studies in animal models of inhalational anthrax. ( 1.2, 14 ) There have been no studies of the safety or pharmacokinetics (PK) of ANTHIM in the pediatric population. Dosing in pediatric patients was derived using a population PK approach. ( 1.2.

Question 2

How does OBILTOXAXIMAB work?

Accepted Answer

OBILTOXAXIMAB works through the following mechanism: 12.1 Mechanism of Action Obiltoxaximab is a monoclonal antibody that binds the PA of B. anthracis [see Microbiology ( 12.4 )] ..

Question 3

What are the most common side effects of OBILTOXAXIMAB?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for OBILTOXAXIMAB. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is OBILTOXAXIMAB the same as Anthim?

Accepted Answer

Anthim is a brand name for OBILTOXAXIMAB. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

OBILTOXAXIMAB

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations